Everett Cunningham
CIK 1564777 · President and CEO · last filed 2026-06-26
Everett Cunningham is a President and CEO who has filed 55 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing, for ARVN, was dated Jun 26, 2026. Across all open-market trades the lifetime net is −$22.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $17.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$17.71M
5
55
-$22.66M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARVN | Director | 41,572 | $8.06 | $335.1K | $0 | 5 | 2026-06-26 |
| QTRX | President and CEO | — | $3.71 | — | $0 | 1 | 2026-01-21 |
| ILMN | SVP, Chief Commercial Officer | 42,614 | $198.16 | $8.44M | $0 | 3 | 2025-07-08 |
| EXACT SCIENCES CORP (EXAS) Delisted | Chief Commercial Officer | 47,041 | $104.91 | $4.94M | -$2.06M | 10 | 2024-05-02 |
| DGX | SVP, Commercial | 38,481 | $231.95 | $8.93M | -$20.61M | 31 | 2019-03-25 |
Recent Filings
55 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-26 | ARVN | Grant (A) | +15,527 | $0 | EDGAR |
| 2026-01-21 | QTRX | Grant (A) | — | $0 | EDGAR |
| 2025-07-08 | ILMN | Tax (F) | −4,248 | -$412.7K | EDGAR |
| 2025-06-27 | ARVN | Grant (A) | +16,025 | $0 | EDGAR |
| 2025-03-07 | ILMN | Grant (A) | +9,103 | $0 | EDGAR |
| 2024-07-09 | ILMN | Grant (A) | +36,860 | $0 | EDGAR |
| 2024-05-31 | ARVN | Grant (A) | +5,899 | $0 | EDGAR |
| 2024-05-02 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +863 | $13.1K | EDGAR |
| 2024-05-01 | EXACT SCIENCES CORP (EXAS) Delisted | Notice (144) | −136 | -$8.2K | EDGAR |
| 2024-03-04 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +2,879 | -$143.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.